Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 1.32 CAD 3.94% Market Closed
Market Cap: 88.3m CAD

Relative Value

There is not enough data to reliably calculate the relative value of ARCH.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARCH Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
4
Median 3Y
24.4
Median 5Y
41.5
Industry
4.3
Forward
43.2
vs History
vs Industry
Median 3Y
-29.7
Median 5Y
-29.5
Industry
33.8
Forward
-18.4
vs History
vs Industry
100
Median 3Y
-46.6
Median 5Y
-46.6
Industry
20.2
vs History
vs Industry
100
Median 3Y
-59.4
Median 5Y
-57.6
Industry
27.4
vs History
vs Industry
Median 3Y
-22.4
Median 5Y
-23.8
Industry
3
vs History
vs Industry
3
Median 3Y
25.1
Median 5Y
44.2
Industry
4.3
Forward
44.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.7
vs History
vs Industry
Median 3Y
-33.2
Median 5Y
-30.3
Industry
19.7
Forward
-7.4
vs History
vs Industry
Median 3Y
-33.2
Median 5Y
-30.3
Industry
25.5
Forward
-6.7
vs History
vs Industry
100
Median 3Y
-47.6
Median 5Y
-47.6
Industry
20.4
vs History
vs Industry
100
Median 3Y
-47.6
Median 5Y
-47.6
Industry
28.3
vs History
vs Industry
100
Median 3Y
-118.8
Median 5Y
-98.1
Industry
2.5

Multiples Across Competitors

ARCH Competitors Multiples
Arch Biopartners Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Arch Biopartners Inc
XTSX:ARCH
87.3m CAD -1 030.2 -36.6 -43.5 -43.5
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 403.6 4 781.9 1 402.4 2 817.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
231.9B USD 5.3 35.3 25 32.3
US
Danaher Corp
NYSE:DHR
167.4B USD 6.9 47.8 25.6 38.7
CH
Lonza Group AG
SIX:LONN
38.7B CHF 5.5 52.7 40.1 40.1
US
Agilent Technologies Inc
NYSE:A
41.8B USD 6 32.1 24.8 29.6
US
IQVIA Holdings Inc
NYSE:IQV
41.3B USD 2.6 32.2 15.4 23.1
CN
WuXi AppTec Co Ltd
SSE:603259
282.2B CNY 6.4 18.8 21.4 21.4
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
30.1B USD 7.6 36.1 25.9 28.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.7B EUR 7 78.3 27.8 45.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Arch Biopartners Inc
XTSX:ARCH
Average EV/EBITDA: 162.5
Negative Multiple: -43.5
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 402.4
5%
280.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
25
6%
4.2
US
Danaher Corp
NYSE:DHR
25.6
5%
5.1
CH
Lonza Group AG
SIX:LONN
40.1
18%
2.2
US
Agilent Technologies Inc
NYSE:A
24.8
13%
1.9
US
IQVIA Holdings Inc
NYSE:IQV
15.4
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
21.4
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
25.9
4%
6.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.8
19%
1.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Arch Biopartners Inc
XTSX:ARCH
Average EV/EBIT: 310
Negative Multiple: -43.5
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 817.5
29%
97.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
32.3
15%
2.2
US
Danaher Corp
NYSE:DHR
38.7
16%
2.4
CH
Lonza Group AG
SIX:LONN
40.1
22%
1.8
US
Agilent Technologies Inc
NYSE:A
29.6
23%
1.3
US
IQVIA Holdings Inc
NYSE:IQV
23.1
15%
1.5
CN
WuXi AppTec Co Ltd
SSE:603259
21.4
23%
0.9
KR
Samsung Biologics Co Ltd
KRX:207940
22.5
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
28.8
5%
5.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
45.7
31%
1.5